Navigation Links
Sodexho, Inc. Announces Patrick E. Connolly as Market President & COO
Date:9/4/2007

Aging. He has worked recently on the Institute for Aging Services' Advisory Commission, further demonstrating his strong commitment to the advancement of quality care for the elderly.

Connolly has a Bachelor of Business degree from Western Illinois University, and a Masters of Management from the J.L. Kellogg School of Management at Northwestern University.

About Sodexho

Sodexho, Inc. (http://www.sodexhoUSA.com) is the leading provider of integrated food and facilities management services in the U.S., Canada and Mexico, with $6.7 billion (USD) in annual revenue and 125,000 employees. Sodexho serves more than ten million customers daily in corporations, health care, long term care and retirement centers, schools, college campuses, government and remote sites. Sodexho, Inc., headquartered in Gaithersburg, Md., is a subsidiary of Sodexho Alliance (http://www.sodexho.com). Sodexho, Inc. funds the Sodexho Foundation (http://www.helpstophunger.org), an independent charitable organization that, since its founding in 1999, has made more than $9.2 million in grants to fight hunger in America.


'/>"/>
SOURCE Sodexho, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. PowderMed Announces Needle-Less Flu Vaccine
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
9. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...Dec. 2 Smile Reminder, the nation,...vice, unveiled the latest in industry,technology ... a digital tool,for capturing and distributing vi...eo patient testimonials onto popular platforms suc...s new tool provides doctors with an effective,bus...
(Date:12/2/2008)...oed for Tuesday, December 2, 2008 at 3 pm CST)--Ra...dical University of South Carolina in Charleston, ...f cancer from exposure to radiation during compute...verstated and that new estimates are several times... MUSC researchers presented their findings at the ...
(Date:12/2/2008)...elationships establish special bonds between partn...nent partnerships, and ultimately, the start of fa...rs place too much emotional weight on their relati...uate their self-worth solely based on the outcomes...hologists term as relationship-contingent self-est...
(Date:12/2/2008)...Dec. 2 In an open lette...ation of Homes and Services for the Aging (AAHSA) ...ways that the Obama administration can make both s... the way America cares for its most vulnerable peo...xpand the Nation,s Work Force: Create Jobs in Agin...
Breaking Medicine News(10 mins):Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2Health News:Too much commitment may be unhealthy for relationships, UH psychology professor says 2
...es, hospitals, nursing homes, Diagnostic centres w...the minimum standards specified by law –// accordi...at has been finalised by the Health Ministry and i...val. The proposed law will apply to all recognise...
...f Philippines, proposes to link-up with tour opera...tment and check-ups with rest and recreation in// ... forum ,Cynthia Carrion, the assistant secretary f...ent of Tourism said, "We are now [coordinating] wi...
...he 11th Keio Medical Science Award from Keio Unive...of Molecular Biophysics and Biochemistry// at Yale...ve symposium conducted by the University on Novemb...rs in recognition of their outstanding achievement...
...to support the Public Health Foundation of India (...ublic Health in India. PHFI is an autonomous// bod...as one-time grant upto Rs. 65 crore only to the in... initially proposes to set up two schools. The loc...
Other Medicine News:Health News:Yale Scientist Received Medical Science Prize From Keio University 2
(Date:12/1/2008)...e-USNewswire/ -- New research has found that the a...ography (CT) scanner in an emergency room can sign...o receive a potentially life-saving treatment. Res...l Center (NSMC)-Salem Hospital in Salem, Mass., wi... Radiological Society of North America (RSNA). , ...
(Date:12/1/2008)...ire/ -- TargeGen has announced that an oral,prese...r, US-based clinical,trial of TG101348 in myelopr...,the 2008 American Society of Hematology (ASH) Me...as follows:, Title: A Phase I S... JAK2-Selective Inhibitor, in Patie...
(Date:12/1/2008)...tasia Treated With ENB-0040 at Children,s Hospital...NTREAL, Dec. 1 Enobia Pharma, an e...ping novel therapeutics for serious bone disorders... its clinical program for hypophosphatasia was dos...rapy (ERT) with ENB-0040 for the treatment of this...
(Date:12/1/2008).... 1 Genaera Corporation...subjects has begun in study MSI-1436C-102 (Study 1... trodusquemine (MSI-1436) in overweight and obese ...for the treatment of type 2 diabetes and obesity w...insulin and leptin pathways through the highly sel...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 1Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 2Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 3Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 4Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 5A reputation for innovation 4796 1A reputation for innovation 4796 2Governor Rendell Announces Resignation of Health Secretary Dr Calvin Johnson 26201 1Governor Rendell Announces Resignation of Health Secretary Dr Calvin Johnson 26201 2Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 1Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 2Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 3Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 4
...22, 2007 /PRNewswire/ -- Principal,investigators f...roliferative for Restenosis) trial, the pivotal st...luting coronary stent,presented today the clinica...investigators confirmed that the study failed to m...ed this conclusion in a,press release on Monday, M...
... FDA Approval of SEROQUEL XR--, WILMINGTON, Del., ... today announced that two analyses from a large-sc...EL XR(TM) (quetiapine,fumarate) Extended-Release T... schizophrenia in adult patients, were presented t...tric Association,(APA). These analyses from the cl...
Other Medicine Technology:Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 2Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
Wipe + Wick
Ophthalmic Ring
Lacrimal Cannula, Straight, Stepped DownSize: 19g x 1-1/2".
PremierEdge™ Slit Knives.
Medicine Products: